Human flora-associated rodents--does the data support the assumptions?

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3815418)

Published in Microb Biotechnol on November 26, 2008

Authors

Peter Silley1

Author Affiliations

1: MB Consult Limited, Lymington, UK. p-s@mbconsult.co.uk

Articles cited by this

The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56

Molecular analysis of commensal host-microbial relationships in the intestine. Science (2001) 12.04

Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A (2002) 9.78

A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A (1999) 3.63

Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek (2002) 3.09

Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut (2001) 2.46

The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol (2001) 2.44

Getting better with bifidobacteria. J Appl Microbiol (2005) 1.81

Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol (2004) 1.73

Effects of the human intestinal flora on germ-free mice. J Appl Bacteriol (1981) 1.64

Ex-germfree mice harboring intestinal microbiota derived from other animal species as an experimental model for ecology and metabolism of intestinal bacteria. Exp Anim (1999) 1.49

Movement and fixation of intestinal microbiota after administration of human feces to germfree mice. Appl Environ Microbiol (2005) 1.46

Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology (1993) 1.36

The use of rats associated with a human faecal flora as a model for studying the effects of diet on the human gut microflora. J Appl Bacteriol (1987) 1.35

Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrob Agents Chemother (1986) 1.31

Implantation of bacteria from the digestive tract of man and various animals into gnotobiotic mice. Am J Clin Nutr (1980) 1.29

Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev (2005) 1.26

Rat intestinal mucosal responses to a microbial flora and different diets. Gut (1995) 1.10

Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol (1999) 1.08

Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol (2003) 1.05

In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr (1992) 1.04

Selection of bacteria originating from a human intestinal microbiota in the gut of previously germ-free rats. FEMS Microbiol Lett (2007) 1.03

Species-specific identification of commercial probiotic strains. J Dairy Sci (2002) 1.03

Antibiotic residues and drug resistance in human intestinal flora. Antimicrob Agents Chemother (1987) 0.98

The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol (1993) 0.97

Effect of selective decontamination of the digestive tract of donor and recipient on the occurrence of murine delayed-type graft-versus-host disease. Med Microbiol Immunol (1988) 0.95

In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates. J Appl Microbiol (2008) 0.93

Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model. Regul Toxicol Pharmacol (2005) 0.89

[Effect of the ingestion of wheat bran on the fecal microbial flora of human donors and of recipient gnotoxenic mice, and on the barrier effects exerted by these flora against various potentially pathogenic microorganisms]. Ann Microbiol (Paris) (1984) 0.89

Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model. Regul Toxicol Pharmacol (2001) 0.87

The influence of incubation pH on the activity of rat and human gut flora enzymes. J Appl Bacteriol (1989) 0.84

The influence of diets and gut microflora on lectin binding patterns of intestinal mucins in rats. Lab Invest (1995) 0.84

The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J Appl Bacteriol (1985) 0.84

[A dynamic study of drug resistance in populations of fecal "Escherichia coli" from axenic mice, fed chlortetracycline continuously and associated with flora from infant, calf and piglet (author's transl)]. Ann Microbiol (Paris) (1981) 0.82

Conversion of IQ to 7-OHIQ by gut microflora. Nutr Cancer (1993) 0.81

Carrageenan gel and aberrant crypt foci in the colon of conventional and human flora-associated rats. Nutr Cancer (2000) 0.78

Effect of dietary fats on endogenous formation of N-nitrosamines from nitrate in germ-free and conventional rats and rats harbouring a human flora. Food Addit Contam (1991) 0.77

Micromorphometrical analysis of rodent related (SPF) and unrelated (human) gut microbial flora in germfree mice by digital image processing. Epidemiol Infect (1996) 0.76